Intra and inter-rater repeatability of brachial artery ultrasound estimates of flow-mediated slowing and flow-mediated dilation.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 04 04 2023
accepted: 09 06 2023
medline: 30 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Flow-mediated slowing (FMS) is a non-invasive measure of endothelial function measured through reactive hyperemia-induced changes in pulse wave velocity (PWV). FMS is suggested to mitigate known pitfalls of flow-mediated dilation (FMD) including suboptimal repeatability and high-operator dependency. However, the few single-rater studies that examined FMS repeatability have shown controversial results and used only regional measurements of PWV, which might not reflect local brachial artery stiffness responses to reactive hyperemia. We assessed the inter- and intra-rater repeatability of ultrasound-based changes in local PWV (FMS) and diameter (FMD). Twenty-four healthy male participants aged 23-75 yr, were examined on two separate days. Reactive hyperemia-induced changes in PWV were calculated using a tailored R-script. The inter- and intra-rater repeatability were tested with the intraclass correlation coefficient (ICC), coefficient of variation (CV), and the Bland-Altman plot estimates. The inter-rater repeatability of FMS (bias: -0.08%; ICC: 0.85; 95% CI: 0.65 to 0.93; CV: 11%) and FMD (bias: -0.02%; ICC: 0.98; 95% CI: 0.97 to 0.99; CV: 7%) showed overall good repeatability over different days. The intra-rater repeatability of FMD (1st rater: bias: 0.27%; ICC: 0.90; 95% CI: 0.78 to 0.96; CV: 14%; 2nd rater: bias: 0.60%; ICC: 0.85; 95% CI: 0.64 to 0.94; CV: 18%) was better than FMS (1st rater: bias: -1.03%; ICC: 0.76; 95% CI: 0.44 to 0.91; CV: 21%; 2nd rater: bias:-0.49%; ICC: 0.70; 95% CI: 0.34 to 0.80; CV: 23%) but not different between raters. Ultrasound-based local measurements of PWV deceleration reactive hyperemia were repeatable among the raters.

Identifiants

pubmed: 37379344
doi: 10.1371/journal.pone.0287759
pii: PONE-D-23-09755
pmc: PMC10306196
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0287759

Informations de copyright

Copyright: © 2023 Marôco et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Hypertens. 2012 Jul;30(7):1399-405
pubmed: 22525207
Eur Heart J. 2019 Aug 7;40(30):2534-2547
pubmed: 31211361
Diabetes Care. 2009 Nov;32 Suppl 2:S314-21
pubmed: 19875572
Hypertension. 2003 Nov;42(5):915-8
pubmed: 12975386
Eur Heart J Cardiovasc Imaging. 2014 Jul;15(7):736-46
pubmed: 24399339
Am J Physiol Heart Circ Physiol. 2011 Feb;300(2):H712; author reply H713
pubmed: 21282474
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Eur J Prev Cardiol. 2016 Apr;23(6):577-83
pubmed: 26209709
Lancet. 1992 Nov 7;340(8828):1111-5
pubmed: 1359209
PLoS One. 2022 May 24;17(5):e0267287
pubmed: 35609038
Atherosclerosis. 2016 May;248:97-109
pubmed: 26994427
Hypertension. 2015 Sep;66(3):698-722
pubmed: 26160955
Eur Heart J. 2006 Feb;27(3):302-9
pubmed: 16267075
Eur Heart J. 2013 Dec;34(45):3501-7
pubmed: 23821401
J Am Heart Assoc. 2015 Nov 13;4(11):
pubmed: 26567372
J Hypertens. 2016 Sep;34(9):1738-45
pubmed: 27488550
Circulation. 2012 Aug 7;126(6):753-67
pubmed: 22869857
Vasc Med. 2020 Oct;25(5):419-426
pubmed: 32490736
Clin Biochem Rev. 2012 May;33(2):49-75
pubmed: 22896744
J Am Coll Cardiol. 2002 Jan 16;39(2):257-65
pubmed: 11788217
Circulation. 2002 Jan 15;105(2):213-7
pubmed: 11790703
J Am Coll Cardiol. 2019 Sep 3;74(9):1237-1263
pubmed: 31466622
Clin Hypertens. 2017 Aug 22;23:17
pubmed: 28852570
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1034-1043
pubmed: 31875700
J Hypertens. 2015 May;33(5):1023-31
pubmed: 25668350
J Med Biol Eng. 2015;35(5):555-565
pubmed: 26500469
JACC Cardiovasc Imaging. 2008 Nov;1(6):739-48
pubmed: 19356510
Mayo Clin Proc Innov Qual Outcomes. 2018 Mar 20;2(2):199-203
pubmed: 30225450
Eur Heart J Cardiovasc Imaging. 2016 Mar;17(3):233-46
pubmed: 26546802
Int J Vasc Med. 2012;2012:903107
pubmed: 22666595
Am J Hypertens. 2016 Sep;29(9):1024-8
pubmed: 27143395

Auteurs

João Luís Marôco (JL)

Integrative Human Physiology Laboratory, Manning College of Nursing & Health Sciences, University of Massachusetts Boston, Boston, MA, United States of America.
Ginásio Clube Português, Research & Development Department, GCP Lab, Lisboa, Portugal.
Centro Interdisciplinar de Estudo da Performance Humana (CIPER), Faculdade de Motricidade Humana, Universidade de Lisboa, Oeiras, Portugal.

Tiago Silvestre (T)

Ginásio Clube Português, Research & Development Department, GCP Lab, Lisboa, Portugal.
Faculdade de Ciências da Saúde e do Desporto, Universidade Europeia, Lisboa, Portugal.

Inês Arrais (I)

Ginásio Clube Português, Research & Development Department, GCP Lab, Lisboa, Portugal.
Centro Interdisciplinar de Estudo da Performance Humana (CIPER), Faculdade de Motricidade Humana, Universidade de Lisboa, Oeiras, Portugal.
Center for Sports Optimization (COD), Sporting Clube de Portugal, Lisbon, Portugal.

Marco Pinto (M)

Ginásio Clube Português, Research & Development Department, GCP Lab, Lisboa, Portugal.

Helena Santa-Clara (H)

Ginásio Clube Português, Research & Development Department, GCP Lab, Lisboa, Portugal.
Centro Interdisciplinar de Estudo da Performance Humana (CIPER), Faculdade de Motricidade Humana, Universidade de Lisboa, Oeiras, Portugal.

Bo Fernhall (B)

Integrative Human Physiology Laboratory, Manning College of Nursing & Health Sciences, University of Massachusetts Boston, Boston, MA, United States of America.

Xavier Melo (X)

Centro Interdisciplinar de Estudo da Performance Humana (CIPER), Faculdade de Motricidade Humana, Universidade de Lisboa, Oeiras, Portugal.
Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Egas Moniz School of Health & Science, Caparica, Almada, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH